Unresectable intrahepatic cholangiocarcinoma
Clinical trials for Unresectable intrahepatic cholangiocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Unresectable intrahepatic cholangiocarcinoma trials appear
Sign up with your email to follow new studies for Unresectable intrahepatic cholangiocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Four-Drug cocktail outsmart bile duct cancer?
Disease control Recruiting nowThis phase II trial is testing whether alternating standard chemotherapy and immunotherapy with a targeted drug called pemigatinib can help people with advanced biliary tract cancers that have FGFR2 alterations. The study includes adults with cancer that cannot be removed by surg…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could your own immune cells fight liver cancer? new trial aims to find out
Disease control Recruiting nowThis study tests a new approach for people with advanced liver cancer that cannot be surgically removed. Participants receive radiation followed by an injection of their own specially trained immune cells (dendritic cells), a pneumonia vaccine to boost immunity, and immunotherapy…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis early-phase trial is testing whether combining a targeted radiation treatment (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be removed by surgery. The study will enrol…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC